Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Total Debt of $439.21 million for Q2 2026, up 57.7% from $278.54 million a year earlier and up 0.8% from the prior quarter.
Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals posted Total Debt of $38.46 million, down 88.9% from FY2024.
- Total Debt has a five-year compound annual growth rate of -23.8% (FY2020 to FY2025).
- By year, Total Debt came in at $347.55 million in FY2024 (+6.3%), $326.8 million in FY2023 (+41.1%), $231.62 million in FY2022 (+70.2%) and $136.08 million in FY2021 (-9.1%).
- The Q2 2026 figure ranks as the highest quarterly Total Debt in data going back to Q2 2011.
- Year over year, Total Debt gained in five of the last eight quarters, with an average decline of 3.9%.
- The high point for year-over-year Total Debt in five years was Q3 2021 (growth of 113.4%); the low point was Q4 2025 (a decline of 88.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $435.51 million (Q1 2026), $38.46 million (Q4 2025) and $232.05 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | 439.21 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439.21 Mn |
| Mar 31, 2026 | 435.51 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 232.05 Mn |
| Jun 30, 2025 | 278.54 Mn |
| Mar 31, 2025 | 349.72 Mn |
| Dec 31, 2024 | 347.55 Mn |
| Sep 30, 2024 | 347.33 Mn |
| Jun 30, 2024 | 342.80 Mn |
| Mar 31, 2024 | 334.51 Mn |
| Dec 31, 2023 | 326.80 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 293.18 Mn |
| Mar 31, 2023 | 232.52 Mn |
| Dec 31, 2022 | 231.62 Mn |
| Sep 30, 2022 | 223.87 Mn |
| Jun 30, 2022 | 144.52 Mn |
| Mar 31, 2022 | 140.24 Mn |
| Dec 31, 2021 | 136.08 Mn |
| Sep 30, 2021 | 162.05 Mn |
Biocryst Pharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();